InvestorsAbout us Career
한 A
CRISPR Foundational PatentLicensing & PartnershipPlatformTherapeuticsCropsPeople

What We Do

For better health,
happier life

Since 1999, ToolGen has been a leading gene editing company worldwide. After developing ZFN (Zinc Finger Nuclease) and  TALEN (Transcription Activator Like Effector Nuclease), ToolGen further came up with CRISPR-Cas9. ToolGen has business  in patent monetization (Licensing and Collaboration), therapeutics, and crops.

Platform

ToolGen leads the gene editing industry through the optimized CRISPR-Cas9 technology and research on various CRISPR-Cas9 related platforms. By doing so, ToolGen develops more efficient and precise gene editing technologies, contributing to the technological advancement of the industry.

Therapeutics

We conduct research to develop treatments for genetic diseases and rare diseases so that humanity can lead a healthy life free from illness.

Crops

We conduct research to improve the traits of major crops by editing their genetic information, aiming to achieve a prosperous life without food shortages.

Licensing

Stronger Together

ToolGen is the only company to have successfully developed CRISPR-Cas9 after ZFN and TALEN in the field of gene scissors technology.As a company with registered patents for CRISPR-Cas9 source technology applicable to eukaryotic cells, we are looking to grow with partners who want to utilize CRISPR-Cas9 technology. We look forward to sharing our technology and accumulated experience with partners who want to utilize CRISPR-Cas9 technology in the future.

..